secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aterian, Inc. (ATER)
CIK:        0001757715
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001437749-25-037738
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aterian receives Nasdaq bid price deficiency notice; 180-day cure period until June 2026
--------------------------------------------------------------------------------

- Nasdaq notified Aterian on Dec 9, 2025 that closing bid price was below $1.00 for 30 consecutive business days.
- Company has until June 8, 2026 to regain compliance by closing at $1.00+ for at least 10 consecutive days.
- If not cured, Nasdaq may grant a second 180-day period if Aterian meets other initial listing standards.
- Failure to cure could result in delisting; company may appeal to a Nasdaq hearings panel.
- No assurance that compliance will be achieved or maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757715/000143774925037738/0001437749-25-037738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757715/000143774925037738/ater20251209_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-037738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer